Hormonal and chemical regulation of paraoxonases in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 688-695

  Cheng, Xingguo ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; ARYLDIALKYLPHOSPHATASE 3; CONSTITUTIVE ANDROSTANE RECEPTOR; GROWTH HORMONE; MESSENGER RNA; PREGNANE X RECEPTOR; SEX HORMONE; TRANSCRIPTION FACTOR NF E2; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; ENZYME REGULATION; FETUS; FETUS LIVER; GENE; GENE EXPRESSION; HYPOPHYSECTOMY; KNOCKOUT MOUSE; LIVER; LIVER LEVEL; LUNG; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PON1 GENE; PON2 GENE; PON3 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEX DIFFERENCE; TISSUE LEVEL; WILD TYPE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; FEMALE; GONADAL STEROID HORMONES; GROWTH HORMONE; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; NF-E2 TRANSCRIPTION FACTOR; PYRIDINES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, MESSENGER; SEX FACTORS; TISSUE DISTRIBUTION;

EID: 84865170739     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.194803     Document Type: Article

References (60)

1. Abdul Shakoor SK and Shalet SM (2003) Effects of GH replacement on metabolism and physical performance in GH deficient adults. J Endocrinol Invest 26:911-918. (Pubitemid 38049174)
2. Arteaga E, Rojas A, Villaseca P, Bianchi M, Arteaga A, and Durán D (1998) In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. Menopause 5:16-23. (Pubitemid 28257382)
3. Augustinsson KB and Barr M (1963) Age variation in plasma arylesterase activity in children. Clin Chim Acta 8:568-573.
4. Aviram M and Rosenblat M (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16:393-399. (Pubitemid 41017622)
5. bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, and Lim SK (2003) Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation. Free Radic Biol Med 34:824-829.
6. Brunelli R, Mei G, Krasnowska EK, Pierucci F, Zichella L, Ursini F, and Parasassi T (2000) Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation. Biochemistry 39:13897-13903.
7. Butterworth M, Lau SS, and Monks TJ (1998) 2-Hydroxy-4-glutathion-S-yl- 17β-estradiol and 2-hydroxy-1-glutathion-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of 17β-estradiol- mediated nephrocarcinogenicity. Carcinogenesis 19:133-139. (Pubitemid 28376835)
8. Cheng X, Maher J, Lu H, and Klaassen CD (2006) Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression. Mol Pharmacol 70:1291-1297. (Pubitemid 44435981)
9. Chiang K, Parthasarathy S, and Santanam N (2004) Estrogen, neutrophils and oxidation. Life Sci 75:2425-2438. (Pubitemid 39180047)
10. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, and Waxman DJ (2006) Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20:1333-1351. (Pubitemid 43801235)
11. Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, et al. (2003) Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364. (Pubitemid 36724529)
12. Costa LG, Cole TB, Jarvik GP, and Furlong CE (2003) Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 54:371-392. (Pubitemid 37386402)
13. Costa LG, Vitalone A, Cole TB, and Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550.
14. Curtin BF, Seetharam KI, Dhoieam P, Gordon RK, Doctor BP, and Nambiar MP (2008) Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J Cell Biochem 103:1524-1535. (Pubitemid 351490720)
15. Draganov DI and La Du BN (2004) Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 369:78-88. (Pubitemid 38161225)
16. Draganov DI, Stetson PL, Watson CE, Billecke SS, and La Du BN (2000) Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275:33435-33442.
17. Ecobichon DJ and Stephens DS (1973) Perinatal development of human blood esterases. Clin Pharmacol Ther 14:41-47.
18. Elhadd TA, Abdu TA, and Clayton R (2001) Hypopituitarism and atherosclerosis. Ann Med 33:477-485. (Pubitemid 32959920)
19. Eybl V, Kotyzová D, Koutenský J, and Glattre E (2004) The effect of estradiol on the oxidative damage and trace element level determined in the liver of rats treated with dimethylarsinic acid. Cent Eur J Public Health 12 (Suppl):S26-S28. (Pubitemid 38568704)
20. Fenkci IV, Serteser M, Fenkci S, and Akyol AM (2006) Effects of intranasal estradiol treatment on serum paraoxonase and lipids in healthy, postmenopausal women. Gynecol Obstet Invest 61:203-207.
21. Gouédard C, Barouki R, and Morel Y (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24:5209-5222. (Pubitemid 38738157)
22. Gutierrez A, Ratliff EP, Andres AM, Huang X, McKeehan WL, and Davis RA (2006) Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. Arterioscler Thromb Vasc Biol 26:301-306. (Pubitemid 43732191)
23. Hartley DP and Klaassen CD (2000) Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology. Drug Metab Dispos 28:608-616. (Pubitemid 30238522)
24. Hernandez JP, Huang W, Chapman LM, Chua S, Moore DD, and Baldwin WS (2007) The environmental estrogen, nonylphenol, activates the constitutive androstane receptor. Toxicol Sci 98:416-426. (Pubitemid 47244812)
25. Hong SC, Zhao SP, and Wu ZH (2006) Probucol up-regulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits. J Cardiovasc Pharmacol 47:77-81. (Pubitemid 44378228)
26. Jaichander P, Selvarajan K, Garelnabi M, and Parthasarathy S (2008) Induction of paraoxonase 1 and apolipoprotein A1 gene expression by aspirin. J Lipid Res 49:2142-2148.
27. Karanth S and Pope C (2000) Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol Sci 58:282-289. (Pubitemid 32042426)
28. Kawamoto T, Kakizaki S, Yoshinari K, and Negishi M (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 14:1897-1905.
29. Kempster SL, Belteki G, Licence D, Charnock-Jones DS, and Smith GC (2012) Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice. Am J Physiol Endocrinol Metab 302:E103-E107.
30. Klaassen CD and Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1-96.
31. Kretschmer XC and Baldwin WS (2005) CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact 155:111-128. (Pubitemid 41188357)
32. Kumon Y, Nakauchi Y, Suehiro T, Shiinoki T, Tanimoto N, Inoue M, Nakamura T, Hashimoto K, and Sipe JD (2002) Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid 9:160-164. (Pubitemid 35205205)
33. Kumru S, Aydin S, Aras A, Gursu MF, and Gulcu F (2005) Effects of surgical menopause and estrogen replacement therapy on serum paraoxonase activity and plasma malondialdehyde concentration. Gynecol Obstet Invest 59:108-112. (Pubitemid 40868080)
34. Legraverend C, Mode A, Wells T, Robinson I, and Gustafsson JA (1992) Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. Faseb J 6:711-718.
35. Li WF, Matthews C, Disteche CM, Costa LG, and Furlong CE (1997) Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics 7:137-144. (Pubitemid 27261846)
36. Mackness MI, Arrol S, Abbott C, and Durrington PN (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104:129-135. (Pubitemid 24035640)
37. Mackness MI, Arrol S, and Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152-154.
38. Mackness MI and Walker CH (1983) Partial purification and properties of sheep serum "A'-esterases. Biochem Pharmacol 32:2291-2296. (Pubitemid 13067981)
39. Mackness MI and Walker CH (1988) Multiple forms of sheep serum A-esterase activity associated with the high-density lipoprotein. Biochem J 250:539-545. (Pubitemid 18067907)
40. Mazur A (1946) An enzyme in animal tissues capable of hydrolysing the phosphorus-fluorine bond of alkyl flurophosphates. J Biol Chem 164:271-289.
41. Mendelsohn ME and Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811. (Pubitemid 29266405)
42. Moser VC, Chanda SM, Mortensen SR, and Padilla S (1998) Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci 46:211-222. (Pubitemid 29069605)
43. Mueller RF, Hornung S, Furlong CE, Anderson J, Giblett ER, and Motulsky AG (1983) Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. Am J Hum Genet 35:393-408. (Pubitemid 13095764)
44. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, and Reddy ST (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444-44449.
45. Ota K, Suehiro T, Arii K, Ikeda Y, Kumon Y, Osaki F, and Hashimoto K (2005) Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. Metabolism 54:142-150. (Pubitemid 40174840)
46. Painson JC, Thorner MO, Krieg RJ, and Tannenbaum GS (1992) Short-term adult exposure to estradiol feminizes the male pattern of spontaneous and growth hormone-releasing factor-stimulated growth hormone secretion in the rat. Endocrinology 130:511-519.
47. Rajdl D, Racek J, Trefil L, and Siala K (2007) Effect of white wine consumption on oxidative stress markers and homocysteine levels. Physiol Res 56:203-212.
48. Rao MN, Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, and Lakshman MR (2003) Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52:1287-1294. (Pubitemid 37351096)
49. Rontu R, Solakivi T, Teisala K, Lehtimäki T, Punnonen R, and Jokela H (2004) Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation. Free Radic Res 38:129-137. (Pubitemid 38181169)
50. Ruiz-Sanz JI, Navarro R, Martínez R, Martín C, Lacort M, Matorras R, and Ruiz-Larrea MB (2001) 17β-Estradiol affects in vivo the low density lipoprotein composition, particle size, and oxidizability. Free Radic Biol Med 31:391-397. (Pubitemid 32675345)
51. Santanam N, Shern-Brewer R, McClatchey R, Castellano PZ, Murphy AA, Voelkel S, and Parthasarathy S (1998) Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res 39:2111-2118. (Pubitemid 28523116)
52. Sorenson RC, Primo-Parmo SL, Kuo CL, Adkins S, Lockridge O, and La Du BN (1995) Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc Natl Acad Sci U S A 92:7187-7191.
53. Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, and Williams SM (2001) Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism 50:319-324. (Pubitemid 32248979)
54. Thomàs-Moyà E, Gianotti M, Lladó I, and Proenza AM (2006) Effects of caloric restriction and gender on rat serum paraoxonase 1 activity. J Nutr Biochem 17:197-203. (Pubitemid 43247414)
55. Thomàs-Moyà E, Gianotti M, Proenza AM, and Lladó I (2007) Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 13:203-209.
56. Topçuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, and Topçuoglu D (2005) The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 205:79-86.
57. Twickler TB, Wilmink HW, Schreuder PC, Cabezas MC, van Dam PS, Koppeschaar HP, Erkelens DW, and Dallinga-Thie GM (2000) Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. J Clin Endocrinol Metab 85:4683-4689. (Pubitemid 32157652)
58. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, and Negishi M (2002) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61:1-6. (Pubitemid 34049505)
59. Waxman DJ and O'Connor C (2006) Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 20:2613-2629. (Pubitemid 44833525)
60. Wehner JM, Murphy-Erdosh C, Smolen A, and Smolen TN (1987) Genetic variation in paraoxonase activity and sensitivity to diisopropylphosphofluoridate in inbred mice. Pharmacol Biochem Behav 28:317-320. (Pubitemid 17158227)